Valeant Pharma Announces Sale Of Obagi Medical Products Business

Industry Reports

Valeant Pharmaceuticals International, Inc announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. Limited partners of the Fund include industry veterans in other geographic markets, such as China Regenerative Medicine International Limited .

"The sale of Obagi marks additional progress in our efforts to streamline our operations and reduce debt," Joseph C. Papa, chairman and CEO, Valeant. "As we continue to transform Valeant, we will remain focused on the core businesses that will drive high value for our shareholders."

Obagi Medical Products is a global specialty pharmaceutical company founded by leading skin care experts in 1988. Obagi products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne and sun damage and are primarily available through dermatologists, plastic surgeons, medical spas and other skin care professionals. More information can be found at

Valeant will use proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility. The transaction is expected to close in the second half of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals.

The Company currently estimates that the full-year 2017 revenue and Adjusted EBITDA (non-GAAP) for the Obagi business would have been approximately $85 million and $30 million, respectively.

In this transaction, Morgan Stanley & Co. LLC served as financial advisor to Valeant, and Norton Rose Fulbright acted as legal advisor to Valeant.

China Regenerative Medicine International Limited is engaged in the research, development and commercialization of innovative bio-medical, healthcare products and medical techniques. CRMI operates seven production plants in mainland China and Hong Kong, and the business is organized across four strategic areas, encompassing tissue engineering, cell therapy, cosmetics and hospital management. More information about China Regenerative Medicine International can be found at

About Valeant
Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Arthur Shannon 
This email address is being protected from spambots. You need JavaScript enabled to view it.
877-281-6642 (toll free)

Elif McDonald
This email address is being protected from spambots. You need JavaScript enabled to view it.
877-281-6642 (toll free)

Media Contact:
Lainie Keller
This email address is being protected from spambots. You need JavaScript enabled to view it.


Market Movers

Rogers Corporation

NYQ : ROG - 22 Aug, 10:33am
+0.56 (+0.50%) After Hours:
Open 112.82 Mktcap 2.06B
High 114.19 52wk Hight 123.38
Low 112.22 52wk Low 51.98
Vol 22304 Avg Vol 121844
Eps 5.55 P/e 27.30
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 22 Aug, 10:35am
+0.035 (+0.543%) After Hours:
Open 6.430 Mktcap 99.59B
High 6.480 52wk Hight 6.990
Low 6.420 52wk Low 4.190
Vol 874829 Avg Vol 6.94M
Eps 0.490 P/e 12.171
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 22 Aug, 10:35am
+0.16 (+0.26%) After Hours:
Open 61.97 Mktcap 169.45B
High 62.34 52wk Hight 66.80
Low 61.92 52wk Low 58.29
Vol 925893 Avg Vol 8.24M
Eps 3.87 P/e 33.64
Currency: USD

Johnson & Johnson

NYQ : JNJ - 22 Aug, 10:34am
-0.10 (-0.07%) After Hours:
Open 133.27 Mktcap 357.91B
High 133.85 52wk Hight 137.08
Low 132.90 52wk Low 109.32
Vol 742786 Avg Vol 5.52M
Eps 7.18 P/e 22.56
Currency: USD

Pfizer, Inc.

NYQ : PFE - 22 Aug, 10:35am
+0.15 (+0.46%) After Hours:
Open 32.76 Mktcap 195.73B
High 33.00 52wk Hight 35.38
Low 32.70 52wk Low 29.83
Vol 1.78M Avg Vol 18.42M
Eps 2.56 P/e 24.07
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 22 Aug, 10:04am
+0.04 (+0.29%) After Hours:
Open 13.63 Mktcap
High 13.65 52wk Hight 16.29
Low 13.63 52wk Low 12.79
Vol 221 Avg Vol 4272
Eps P/e
Currency: USD